Manufacturer record
Glenmark Pharmaceutica ls Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Glenmark Pharmaceutica ls Ltd (Himachal Pradesh) were declared Not of Standard Quality between February 2024 and February 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Glenmark Pharmaceutica ls Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets I.P. 40 mg (Telma 40) | I8220890Mfg 2022-12 · Exp 2025-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Feb 2024 |
| Telmisartan Tablets 40 mg and Amlodipine 5 mg Tablets IP (Telma AM) | 5230355Mfg 2023-03 · Exp 2026-02 | Assay & Dissolution of Telmisartan & AmlodipineAssay | CDL KolkataCDSCO lab | Feb 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.